Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Nature Medicine2012Vol. 19(1), pp. 57–64
Citations Over TimeTop 1% of 2012 papers
Mélanie Bruchard, Grégoire Mignot, Valentin Dérangère, Fanny Chalmin, Angélique Chevriaux, Frédérique Végran, Wilfrid Boireau, B. Simon, Bernhard Ryffel, Jean‐Louis Connat, Jean Kanellopoulos, François Martin, Cédric Rébé, Lionel Apétoh, François Ghiringhelli
Related Papers
- → NLRP3 licenses NLRP11 for inflammasome activation in human macrophages(2022)57 cited
- → Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome(2021)37 cited
- Molecular mechanisms regulating NLRP3 inflammasome activation(2016)
- The inflammasome as future therapeutic target: Development of inflammasome challenge tests(2014)
- → CARD-only proteins (COPs) inhibit uric acid crystal-induced inflammasome activation and ameliorate gout(2023)